ERT
-
INCIVEK is well tolerated with commonly used Atripla- and Reyataz-based HIV treatment regimens
Phase 2 study of INCIVEK combination regimen shows 74 percent of people co-infected with hepatitis C, HIV had undetectable hepatitis C virus 12 weeks after treatment ended.
ERT | 30 April 2012
-
Genetic Technologies receives CLIA certificate of compliance from Centers for Medicare and MedicAid Services, USA
Genetic Technologies announced that it has received the Certificate of Compliance for its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) regulations as administered by the Centers for Medicare and Medicaid Services (CMS).
ERT | 21 February 2012
-
Boehringer Ingelheim single combination of telmisartan and amlodipine provides 24-hour blood pressure reduction and control
Boehringer Ingelheim has released a new anti-hypertensive drug (TWYNSTA) containing a unique combination of telmisartan and amlodipine. Very often, hypertension sufferers take up to four drugs to reach an acceptable blood pressure (BP) more effectively. The single-pill combination drug is taken once daily and provides additional therapeutic and cardiovascular (CV) benefits.
ERT | 02 February 2012
-
Agilent Technologies’ LC/MS manufacturing achieves ISO 13485 certification
Achieves internationally recognized standard of quality management for the design and manufacture of medical devices.
ERT | 08 September 2011
-
NCCN and experts from China collaborate to develop cancer guidelines
The National Comprehensive Cancer Network (NCCN) announces the launch of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) – China Editions for Colon, Kidney, Non-Small Cell Lung, and Ovarian Cancers, which have been translated in…
ERT | 28 July 2011
-
ERT offers ePRO solutions to clinical trial sponsors
ERT launched its suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market continues to grow, ePRO tools have increasingly become more sophisticated, with their development reflecting the diverse needs of sponsors and facilit…
ERT | 09 March 2011
-
Bayer builds new facility in Wuppertal
Bayer HealthCare is building a new facility center in Wuppertal on an area of some 1,000 square meters for the biotechnological production of pharmaceuticals to be used in clinical trials. The investment in this project amounts to 35 million Eur…
ERT | 22 February 2011
-
EnviroCooler is first ISTA certified thermal lab in the world
EnviroCooler's thermal qualification laboratory has become the first laboratory in the world to be independently certified by the ISTA to perform testing under the newly released ISTA Standard 20 and 7E. ISTA Standard 20 is the validation proces…
ERT | 01 November 2010
-
ISTA 7E Converter: online modeling tool
The 7E Converter is the first online ISC thermal modeling tool offered by ISTA.
ERT | 01 November 2010
-
ISTA 7E certified coolers
EnviroCooler announces the availability of the first ISTA 7E certified parcel-load coolers, the EnviroCooler Ice-Lockers. The launch of the independently certified coolers by EnviroCooler is the first step forward to an unified approach to establish…
ERT | 01 October 2010
